SMOFlipid Disease Interactions
There are 2 disease interactions with SMOFlipid (fat emulsion).
Fat emulsion (applies to SMOFlipid) hypertriglyceridemia
Major Potential Hazard, Moderate plausibility. Applicable conditions: Hyperlipidemia, Diabetes Mellitus, Obesity
Parenteral nutrition fat emulsion products are contraindicated in patients with severe lipid metabolism disorders characterized by hypertriglyceridemia (serum triglycerides greater than 1000 mg/dL). Patients with conditions such as inherited lipid disorders, diabetes mellitus, obesity, or metabolic syndromes are at increased risk while in treatment and should be monitored closely.
References (1)
- (2023) "Product Information. Smoflipid (fat emulsion, intravenous)." Fresenius Kabi USA, LLC, SUPPL-10
Fat emulsion (applies to SMOFlipid) renal impairment
Moderate Potential Hazard, Moderate plausibility. Applicable conditions: Renal Dysfunction
Parenteral nutrition fat emulsion products may cause aluminum toxicity and patients with renal impairment, including preterm neonates, are at increased risk. Caution and monitoring are advised.
References (1)
- (2023) "Product Information. Smoflipid (fat emulsion, intravenous)." Fresenius Kabi USA, LLC, SUPPL-10
Switch to consumer interaction data
SMOFlipid drug interactions
There is 1 drug interaction with SMOFlipid (fat emulsion).
SMOFlipid alcohol/food interactions
There are 2 alcohol/food interactions with SMOFlipid (fat emulsion).
More about SMOFlipid (fat emulsion)
- SMOFlipid consumer information
- Check interactions
- Compare alternatives
- Pricing & coupons
- Side effects
- Dosage information
- During pregnancy
- Drug class: intravenous nutritional products
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.